Editor’s note: This article has been revised as of 6/8/22 due to a substantial number of revisions to the original data provided by BDSA
New Cannabis Ventures offers readers this easy-to-read exclusive summary of BDSA’s monthly cannabis sales data for 11 states.
On May 20th, BDSA announced improvements to its industry data. Our April coverage includes finer detail of category, brand and product reporting, a refinement to the process of highly discounted items and a restatement of the total size of the California market to better align with state published data.
Looking at a per-day basis, April sales as covered by cannabis data analytics firm BDSA expanded sequentially in 10 out of 11 states. Compared to a year ago, sales were down in 7 markets, mostly driven by declining flower growth. In this review, we will look at the markets one-by-one, beginning with the eastern markets and then concluding with the western markets. In total, sales across the 11 markets totaled $1.69 billion during the month.
Eastern Markets
BDSA provides coverage for Florida, Illinois, Maryland, Massachusetts, Michigan and Pennsylvania. In April, year-over-year growth ranged from -7.4% in Maryland to 24.7% in Michigan. Note that Florida, Maryland and Pennsylvania are medical-only markets.
Florida Cannabis Sales
In April, sales rose 5.1% from March to $186.2 million, up 21.6% from a year ago. Flower sales grew 38%, as pre-rolls declined 13%. Concentrates increased 27% and ingestibles expanded 1%.
Illinois Cannabis Sales
We previously published data released by the state showing that sales rose 0.4% from March and 8.9% from April 2021. BDSA estimated sales of $163.6 million, up 0.4% sequentially and 8.9% from a year ago. Compared to last year, flower sales expanded 5%. Pre-rolls grew 17%, and ingestibles gained 6%. Concentrates increased 14%.
Maryland Cannabis Sales
Sales fell 1.5% from March to $44.3 million, down 7.4% from a year ago. Flower sales decreased 9%, while pre-rolls fell 12%. Ingestibles grew 6%, while concentrates dropped 8%.
Massachusetts Cannabis Sales
Sales grew 3.3% from March and 13.9% compared to a year ago to $146.7 million. Flower sales expanded 4%, pre-rolls gained 34%, ingestibles increased 21% and concentrates grew 16%.
Michigan Cannabis Sales
We had previously written about data released by the state indicating that Michigan cannabis sales increased 27% compared to both March and a year ago. BDSA estimated sales of $195 million, up 26.8% sequentially and 24.7% from a year ago. Flower sales increased 24% and concentrates gained 48%. Pre-rolls grew 45%, and ingestibles declined 9%.
Pennsylvania Cannabis Sales
Sales fell 1.9% in April to $102.1 million, down 5.4% compared to a year ago. Flower sales declined 1.8% year-over-year, concentrates fell 9%, while ingestibles gained 0.5%.
Western Markets
BDSA provides coverage for Arizona, California, Colorado, Nevada and Oregon. In April, year-over-year growth ranged from -35.8% in Nevada to -10.1% in Arizona compared to a year ago.
Arizona Cannabis Sales
Combined sales of $112.3 million were up 0.6% from March and down 10.1% compared to April 2021, which was the first month when adult-use sales were included. Medical sales of $48.7 million were up 7% sequentially and down 32% from a year ago. Adult-use sales of $63.6 million declined 4% from March and increased 20% year-over-year. Flower sales were down 21% from a year ago, while pre-rolls gained 47%. Concentrates fell 8%, and ingestibles decreased 3%.
California Cannabis Sales
April release included a restatement of the total size of the California market to better align with state published data. California sales increased 5.9% sequentially to $427.8 million and fell 12.4% compared to a year ago. Flower sales were down 23%, while pre-rolls gained 8%. Ingestibles fell 14%, while concentrates dropped 6% from a year ago during April.
Colorado Cannabis Sales
Sales grew 3.3% in April compared to March, dropping 18.7% from a year ago to $167.8 million. Flower sales were down 29%, with pre-rolls falling 1%, ingestibles declining 14% and concentrates dropping 10% from a year ago.
Nevada Cannabis Sales
Sales decreased 5.9% compared to March, falling 35.8% from a year ago to $56.4 million. April flower sales decreased 44% from a year ago. Concentrates dropped 23%, while ingestibles fell 33% and pre-rolls declined 28%.
Oregon Cannabis Sales
Sales in April grew 1.5% from March to $89.8 million, down 18.7% from a year ago. Flower sales were down 31% year-over-year. Ingestibles grew 4%, while pre-rolls declined 10% and concentrates decreased 12%.
For readers interested in a deeper look at cannabis markets across these eleven states and more, including segmentation by additional product categories, brand and item detail, longer history, and segmentation by product attributes, learn how BDSA Solutions can provide you with unlimited access to the most accurate and actionable data and analysis.
